Highlights Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
2.45 ^USD	-3.16%		-4.30%	-18.06%

10/06	Transcript : Nautilus Biotechnology, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:40 AM
30/04	Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/23/02	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	02/23/02	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23/23/23	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/23/23	CI
Nautilus Biotechnology Expands to San Diego	26/23/26	CI
Nautilus Biotechnology, Inc. Partners with the Translational Genomics Research Institute to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma	19/23/19	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01	CI
Nautilus Biotechnology Shares Rise After Company's Q2 Loss Narrows	02/22/02	MT
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/22/02	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	03/22/03	CI
NAUTILUS BIOTECHNOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	25/22/25	AQ
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	24/22/24	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Nautilus Biotechnology Posts Narrower Q3 Loss	02/21/02	MT
Nautilus Biotechnology : Posts Wider Q2 Loss	10/21/10	MT
Nautilus Biotechnology, Inc. Reported Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021	10/21/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Highlights

Filters